Farnesyltransferase inhibitor LB42708 disables oncogenic RAS signaling and overcomes gefitinib resistance in NSCLC via FTase α-subunit and RAS degradation. [PDF]
Luo G +23 more
europepmc +1 more source
Farnesyl Transferase Inhibitors as a Novel Strategy for Targeting KRAS-Dependent Cancers. [PDF]
Kargbo RB.
europepmc +1 more source
Does Ras/Rho Have Skin in the Game: The Importance of the Isoprenoid Biosynthesis Pathway in Merkel Cell Carcinoma Cell Lines. [PDF]
Blaha LN +3 more
europepmc +1 more source
Benzoate Drugs for Traumatic Brain Injury. [PDF]
Pahan S, Pahan K.
europepmc +1 more source
Defining proteoform-specific interactions for drug targeting in a native cell signalling environment. [PDF]
Lutomski CA +10 more
europepmc +1 more source
Selection of specific and efficient siRNAs in new cellular model for Hutchinson-Gilford progeria syndrome therapy. [PDF]
Dzianisava V +3 more
europepmc +1 more source
Lamin A/C as a Molecular Link Between Nuclear Organization, Chromatin Dynamics, and Tumor Progression. [PDF]
Foglini C, Scotlandi K, Pasello M.
europepmc +1 more source
Localization of the PelC and PelE effectors to the <i>Legionella</i>-containing vacuole through host-mediated prenylation and their role in intracellular proliferation. [PDF]
Shin CJ +3 more
europepmc +1 more source
Alpha-Synuclein Inhibits the Secretion of Extracellular Vesicles through Disruptions in YKT6 Lipidation. [PDF]
Tsunemi T +9 more
europepmc +1 more source
Engineering protein prenylation: an emerging tool for selective protein modification. [PDF]
Venkatachalapathy S +3 more
europepmc +1 more source

